# Associate Dir, Health Systems, Medical Outcomes Science Liaison (North Central-Chicago) at Alnylam Pharmaceuticals

> United States · Junior · Other · open. Source: https://alderhq.app/jobs/greenhouse%3Aalnylampharmaceuticals%3A4400662009 (read 2026-11-22).

## Facts (observed)

- Company: [Alnylam Pharmaceuticals](https://alderhq.app/companies/alnylam-pharmaceuticals)
- Location text: Chicago, IL; United States
- Where it can be done from (inferred): United States (evidence: "Location: Chicago, IL; United States")
- Posted: 2026-09-16 (67 days ago)
- First seen by alder: 2026-11-04 · last verified: 2026-11-19
- Reposted: 0 times · edited: 1 times
- Apply on the employer's site: https://job-boards.greenhouse.io/alnylampharmaceuticals/jobs/4400662009

## Pay and sponsorship

- Posted pay: $188k–$254k per year (from the listing's pay field)
- Market band for similar posted roles (Chicago, n 141): p25 $55k, median $90k, p75 $141k

## Description (the employer's text)

### Overview

The Health System Medical Outcomes Science Liaison (HS MOSL) is a field-based scientific expert who serves as Alnylam's primary medical liaison within integrated delivery networks (IDNs), academic health systems, and organized healthcare entities. The HS MOSL engages formulary decision makers, C-suite healthcare leaders, clinical pharmacists, and broader clinical leaders who influence formulary and access decisions - providing balanced, evidence-based scientific and health economic information that supports informed formulary, access, and clinical pathway decisions while identifying collaborative research opportunities that advance evidence generation.

Territory includes: ND, SD, MN, MI, IN, IL, KY, MO, IA, KS, NE

### Key Responsibilities

- Engage and build peer-level relationships with formulary decision makers, C-suite healthcare leaders, clinical pharmacists, pharmacy directors, and key clinical leaders who influence formulary decisions within IDNs and health systems.
- Conduct balanced, evidence-based scientific exchange to address data needs, gather insights, and communicate the clinical and economic value of Alnylam's portfolio.
- In collaboration with the Health System Director (HSD), develop account-specific strategic plans including a detailed assessment of key influencers and decision makers.
- Collect and share evidence gaps and insights to inform Alnylam's Value, Evidence, and Strategy (VESt) Team and advance meaningful data generation.
- Engage health system stakeholders in evidence-based scientific and outcomes-focused dialogue, drawing on relevant clinical and health economic data to support awareness of diagnostic and treatment considerations across the disease area at the system level.
- Identify scientific research collaboration opportunities including real-world evidence generation by leveraging internal stakeholders (Medical Affairs, Value & Access, VESt).
- Provide HEOR and outcomes data to support formulary review processes, clinical pathway development, and health system value assessments.
- Support regional and national IDN/healthcare systems congresses as needed.
- Collaborate closely with MSL colleagues to ensure integrated territory-level scientific strategy across clinical and system-level stakeholders.
- Maintain a thorough understanding of compliance requirements and applicable PhRMA Codes, OIG guidelines, FDA laws, and Alnylam's policies.
- Apply business acumen to prioritize health system engagements that maximize scientific impact and access for patients.
- Independently and proactively applies strategic thinking, scientific expertise, engagement excellence, integrity-driven conduct, and cross-functional collaboration within the health system driving strong execution and continuous improvement across access stakeholder engagement.
### Qualifications

- Required: Advanced degree - MD, DO, PharmD, or PhD in a relevant life science discipline. HEOR fellowship, MS, MBA, or MPH is a plus.
- 5+ years of Medical Affairs experience in pharmaceutical or biotech; prior field-based experience working directly with health systems or IDNs strongly preferred. Experience with federal health systems (VA, DoD) is a plus.
- Demonstrated understanding of pharmacoeconomic and health outcomes research principles.
- Solid working knowledge of US healthcare ecosystems, IDN structure, and formulary decision-making processes.
- Strong therapeutic area knowledge; rare disease experience preferred.
- Solid working knowledge of regulatory and compliance environment including PhRMA, OIG, and FDA guidelines.
- Excellent written and verbal communication skills; ability to engage diverse audiences from clinical staff to C-suite system leaders.
- Ability to travel up to 75%; must reside within assigned territory. Valid driver's license required.
### About Alnylam

We are the leader in RNAi therapeutics – a revolutionary approach with the potential to transform the lives of people with rare and common diseases. Built on Nobel Prize-winning science, Alnylam has delivered the breakthroughs that made RNAi therapeutics possible and are just at the beginning of what’s possible. Our deep pipeline, late-stage programs, and bold vision reflect our core values: fierce innovation, passion for excellence, purposeful urgency, open culture and commitment to people. We're proud to be a globally recognized top employer, where an authentic, inclusive culture and breakthrough thinking fuel one another.

---
Data: alder (https://alderhq.app). Cite https://alderhq.app/jobs/greenhouse%3Aalnylampharmaceuticals%3A4400662009 and the date you read it. Observed facts come from the employer's own listing; location reach, level, family and skills are inferences.
